Denali Therapeutics (DNLI) FCF Margin (2018 - 2023)
Denali Therapeutics (DNLI) reported FCF Margin of 7058.48% for Q3 2023, up 2723282.0% year-over-year from N/an in Q3 2022, and down 17838.85% on a QoQ basis from 39.35% in Q2 2023.
Denali Therapeutics (DNLI) has 6 years of FCF Margin data on file, last reported at 7058.48% in Q3 2023.
- Quarterly FCF Margin rose 2723282.0% year-over-year to 7058.48% in Q3 2023, while the trailing twelve-month figure through Jun 2024 was 31736.31% (down 3164650.0% YoY) and the FY2023 annual result came in at 112.22%, up 713263.0% from the prior year.
- FCF Margin retreated to 7058.48% in Q3 2023 per DNLI's latest filing, from 39.35% in the prior quarter.
- Across five years, FCF Margin topped out at 161.84% in Q4 2020 and bottomed at 5024000.0% in Q1 2021.
- The 5-year median for FCF Margin is 742.48% (2020), against an average of 299484.53%.
- The widest annual swing landed in 2021, when FCF Margin plunged 491751731 bps; it then jumped 502382862 bps in 2022.
- Tracing DNLI's FCF Margin over 5 years: stood at 124040.62% in 2019, then surged by 100 bps to 161.84% in 2020, then tumbled by 465 bps to 591.06% in 2021, then fell by 3 bps to 611.43% in 2022, then sank by 1054 bps to 7058.48% in 2023.
- Per Business Quant, the three latest DNLI FCF Margin figures stand at 7058.48% (Q3 2023), 39.35% (Q2 2023), and 184.62% (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -7,058.48% |
| Jun 30, 2023 | -39.35% |
| Mar 31, 2023 | -184.62% |
| Dec 31, 2022 | -611.43% |
| Sep 30, 2022 | -34,291.30% |
| Jun 30, 2022 | -94.74% |
| Mar 31, 2022 | -171.38% |
| Dec 31, 2021 | -591.06% |
| Sep 30, 2021 | -780.21% |
| Jun 30, 2021 | -363.00% |
| Mar 31, 2021 | -5,024,000.00% |
| Dec 31, 2020 | 161.84% |
| Sep 30, 2020 | -36,240.00% |
| Jun 30, 2020 | -726.53% |
| Mar 31, 2020 | -106,482.69% |
| Sep 30, 2019 | -124,040.63% |
| Jun 30, 2019 | -54,449.49% |
| Mar 31, 2019 | -758.43% |
| Dec 31, 2018 | 71.51% |
| Sep 30, 2018 | -2,824.27% |
| Jun 30, 2018 | -2,572.57% |
| Mar 31, 2018 | 5,154.45% |